HCMCT Manipal Hospitals Dwarka saves the life of a 15-year-old Iraqi boy suffering from a rare nasopharyngeal angiofibroma

  • In a rare occurrence, HCMCT Manipal Hospitals, Dwarka treats a 15-year-old boy from Iraq for nasopharyngeal angiofibroma via endonasal endoscopic surgery

Dwarka, November 04, 2022: Recently, a 15-year-old boy from Iraq was successfully treated at HCMCT Manipal Hospitals, Dwarka for nasopharyngeal angiofibroma (a rare tumor) through endonasal endoscopic surgery. The patient came to the hospital with a history of nasal obstruction and recurrent nasal bleeding for the past one year. Upon further diagnosis, it was found that there was a large hyper-vascular tumour in his left nasopharynx that had extended to the parapharyngeal space, leading to nasopharyngeal angiofibroma. Looking at his condition, Dr. Ashish and Dr. Shubham immediately decided to perform endonasal endoscopic surgery to save the life of the patient.

Nasopharyngeal angiofibroma is a rare tumour found only in teenage males between the age of 10-20 years and usually causes excessive and profuse nasal bleeding. These tumours pose a treatment challenge as they can bleed profusely during surgery. Although this tumour has a predictable growth pattern and is generally not found in the parapharyngeal space, this particular case posed a big treatment challenge as the patient had undergone prior surgery and radiotherapy in his native country. The patient was planned for tumour embolization and endonasal endoscopic in which the tumour was totally removed after a 6-hour surgery and with blood loss of approximately 700 ml.

Addressing the condition of the patient, Dr. Ashish Vashishth, Consultant-Otorhinolaryngology, Head and Neck and Cranial Base Surgery, Ear, Nose and Throat, HCMCT Manipal Hospitals, Dwarka said, “The patient was previously operated on for this condition in his native country, which posed a major challenge in the treatment. However, our excellent team was able to manage the situation, and the patient showed no complications post-surgery. Although the patient lost almost 700 ml of blood during the surgery, he did not require any blood transfusion and recovered uneventfully in 3 days with no scar or incisions over his face or neck.”

Dr. Shubham Jain, HOD and Consultant – Surgical Oncology, HCMCT, Manipal Hospitals, Dwarka, said, “It was a very complex surgery because of the location of the tumour. Blood loss is very common in this surgery, but the patient was able to take the treatment successfully and he was shifted from the ICU right after one day. Careful planning, multi-departmental collaboration, and robust operative and critical care teamwork can lead to optimal results in such advanced tumours.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago